Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Cancer Surviv. 2016 May 11;10(6):1051–1057. doi: 10.1007/s11764-016-0548-1

Table 4.

Treatment, demographic factors and the risk of hypothesized late effects among testicular cancer survivors diagnosed in Utah between 1991 to 2007

No Eve Event Crude HR(95%CI) Adjusted HR* (95%CI)
Treatment
 Radical orchiectomy only 186 48 1.00 1.00
 Radical orchiectomy & chemotherapy 83 32 1.33 (0.85,2.08) 1.92 (1.06,3.47)
 Radical orchiectomy & radiotherapy 165 64 1.47 (1.01,2.14) 1.04 (0.61,1.78)
 Other therapies** 6 4 1.49 (0.54,4.15) 1.6 (0.53,4.88)
Retroperitoneal lymph node dissection
 No 344 136 1.00 1.00
 Yes 96 12 0.98 (0.54,1.79) 1.17 (0.62,2.23)
Stage
 Localized 328 111 1.00 1.00
 Regional 72 23 0.96 (0.61,1.51) 1.12 (0.7,1.8)
 Advanced 40 14 0.8 (0.46,1.39) 1.01 (0.54,1.88)
Year of diagnosis
 1991–1995 74 66 1.00 1.00
 1996–2000 137 55 1.08 (0.73,1.6) 0.99 (0.67,1.47)
 2001–2005 174 26 1.14 (0.68,1.93) 0.95 (0.54,1.65)
 2006–2007 55 1 0.43 (0.06,3.2) 0.33 (0.04,2.63)
Age at cancer diagnosis
 <35 307 78 1.00 1.00
 35–39 66 27 1.55 (1,2.41) 1.33 (0.85,2.09)
 40–44 32 23 2.18 (1.37,3.47) 1.99 (1.23,3.25)
 45–49 27 15 2.06 (1.18,3.58) 1.93 (1.09,3.41)
 50+ 8 5 5.29 (2.12,13.19) 4.39 (1.66,11.67)
Race
 White 436 147 1.00 1.00
 Non-White 4 1 0.72 (0.1,5.17) 0.55 (0.08,4.04)
BMI
 <25 kg/m2 191 37 1.00 1.00
 25–29.9 kg/m2 197 77 1.85 (1.25,2.74) 1.65 (1.1,2.47)
 30+ kg/m2 52 34 2.88 (1.81,4.61) 2.87 (1.78,4.63)
Marital status
 Divorced, widowed, Unmarried 156 49 1.00 1.00
 Married 284 99 1.06 (0.75,1.49) 0.98 (0.69,1.39)
Family history of any cancer
 No 221 73 1.00 1.00
 Yes 219 75 0.84 (0.6,1.15) 0.82 (0.59,1.14)
Family history of testicular cancer
 No 428 142 1.00 1.00
 Yes 12 6 1.91 (0.84,4.33) 1.81 (0.76, 4.31)
*

Adjusted for age at diagnosis, stage, histology, year of diagnosis, treatment, RPLND where appropriate

**

Unknown, radiotherapy only, chemotherapy only, or radiation+chemotherapy+orchiectomy.